{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:39:29Z","timestamp":1785407969082,"version":"3.56.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Obesity is a multifactorial chronic disease associated with multiple health complications. While bariatric surgery and endoscopic sleeve gastroplasty (ESG) are effective treatments for severe obesity, patients may still experience challenges such as weight regain or inadequate weight loss. As a result, combining these interventions with adjunctive treatment such as anti-obesity medication (AOM) or probiotics has become an area of increasing clinical interest. This narrative review summarizes the current evidence on the effect of combining surgical or endoscopic bariatric interventions with AOM or probiotics. Available studies suggest that the combination of GLP-1 receptor agonists (GLP-1 RA) and ESG leads to more weight loss than ESG alone. In contrast, non-GLP-1 RA medication show less consistent benefits and generally lower weight loss. GLP-1 RAs and tirzepatide show clinically relevant short term weight loss in patients with weight regain or insufficient weight loss after bariatric surgery. Other AOM, such as topiramate, phentermine, orlistat and bupropion\/naltrexone result in more modest and variable outcomes. Relatively small studies on probiotics and prebiotics in combination with bariatric surgery do not find a statistically significant difference in weight loss between probiotic and placebo groups. Although small benefits in waist circumference, liver enzymes and vitamin uptake are mentioned, the effects are modest and not consistent across studies. In conclusion, combining AOM, especially GLP-1 RAs, with surgical or endoscopic obesity treatments appears to enhance weight loss in patients with suboptimal outcomes. These findings support the use of AOM as an adjunct to bariatric procedures. In addition, additional adequately powered studies are needed to evaluate the role for probiotics in improving weight loss after bariatric surgery. Future research should focus on long-term outcomes, side effects, and identifying patient subgroups that may benefit most from combined therapy.<\/jats:p>","DOI":"10.3389\/fendo.2026.1680182","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:33:44Z","timestamp":1770183224000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of combining surgical or endoscopic bariatric interventions with anti-obesity medication or probiotics on weight loss: a narrative review"],"prefix":"10.3389","volume":"17","author":[{"given":"J. R.","family":"de Waal","sequence":"first","affiliation":[{"name":"Section of Vascular Medicine, Department of Internal Medicine, Amsterdam University Medical Centre","place":["Amsterdam, Netherlands"]},{"name":"Department of Internal Medicine, Spaarne Gasthuis","place":["Hoofddorp, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nieuwdorp","sequence":"additional","affiliation":[{"name":"Section of Vascular Medicine, Department of Internal Medicine, Amsterdam University Medical Centre","place":["Amsterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. E. A.","family":"Gerdes","sequence":"additional","affiliation":[{"name":"Section of Vascular Medicine, Department of Internal Medicine, Amsterdam University Medical Centre","place":["Amsterdam, Netherlands"]},{"name":"Department of Internal Medicine, Spaarne Gasthuis","place":["Hoofddorp, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"B2","article-title":"Obesity: identification, assessment and management","volume-title":"NICE clinical guidelines","year":"2022"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-021-05394-x","article-title":"What is weight loss after bariatric surgery expressed in percentage total weight loss (%TWL)? A systematic review","volume":"31","author":"Van Rijswijk","year":"2021","journal-title":"Obes Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.cgh.2020.09.055","article-title":"Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity","volume":"19","author":"Sharaiha","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-024-07479-9","article-title":"Dutch Audit for Treatment of Obesity Research Group. Evidence-based classification for post-bariatric weight regain from a benchmark registry cohort of 18,403 patients and comparison with current criteria","volume":"33","author":"Franken","year":"2023","journal-title":"Obes Surg"},{"key":"B6","article-title":"Obesity: definition, comorbidities, causes, and burden","volume-title":"Endotext","author":"Apovian","year":"2020"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i6.1107","article-title":"Current status of endoscopic sleeve gastroplasty: an opinion review","volume":"26","author":"Wang","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112678","article-title":"The links between gut microbiota and obesity and obesity-related diseases","volume":"147","author":"Geng","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.gie.2020.10.016","article-title":"Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss","volume":"93","author":"Badurdeen","year":"2021","journal-title":"Gastrointest Endosc"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2024.274","article-title":"Endoscopic sleeve gastroplasty combined with anti-obesity medication for better control of weight and diabetes","volume":"58","author":"Chung","year":"2025","journal-title":"Clin Endosc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/a-2463-9784","article-title":"Efficacy of anti-obesity medication (AOM) and endoscopic gastric remodeling (EGR): analysis of combination therapy with optimal timing and agents","volume":"12","author":"Jirapinyo","year":"2024","journal-title":"Endosc Int Open"},{"key":"B12","doi-asserted-by":"publisher","first-page":"100112","DOI":"10.1016\/j.obpill.2024.100116","article-title":"Outcomes of concomitant anti-obesity medication use with endoscopic sleeve gastroplasty in clinical US settings","volume":"11","author":"Gala","year":"2024","journal-title":"Obes Pillars"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006748","article-title":"GLP-1RA in the real world: 1-year compliance and outcomes of semaglutide use in patients with or without previous history of bariatric surgery","author":"Medhati","year":"2025","journal-title":"Ann Surg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-024-07137-0","article-title":"Semaglutide and tirzepatide for the management of weight recurrence after sleeve gastrectomy: a retrospective cohort study","volume":"34","author":"Jamal","year":"2024","journal-title":"Obes Surg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-020-04880-4","article-title":"Patterns of\u00a0weight loss medication utilization and outcomes following bariatric surgery","volume":"25","author":"Edgerton","year":"2021","journal-title":"J\u00a0Gastrointest Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-015-2044-5","article-title":"Pharmacotherapy in conjunction with a diet and exercise program for the treatment of weight recidivism or weight loss plateau post-bariatric surgery: a retrospective review","volume":"26","author":"Schwartz","year":"2016","journal-title":"Obes Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.orcp.2025.02.004","article-title":"Tackling suboptimal clinical response after metabolic bariatric surgery: impact of tirzepatide on weight loss and body composition","volume":"19","author":"Stoll","year":"2025","journal-title":"Obes Res Clin Pract"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-023-06736-7","article-title":"Treatment with anti-obesity drugs in weight regain after bariatric surgery: a retrospective cohort study","volume":"33","author":"Boger","year":"2023","journal-title":"Obes Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23736","article-title":"Effectiveness of semaglutide versus liraglutide for treating post-metabolic and bariatric surgery weight recurrence","volume":"31","author":"Murvelashvili","year":"2023","journal-title":"Obes (Sil Spring)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2023.04.2092","article-title":"Combining transoral outlet reduction with pharmacotherapy yields similar 1-year efficacy with improved safety compared with surgical revision for weight regain after Roux-en-Y gastric bypass (with videos)","volume":"98","author":"Jirapinyo","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-022-06191-w","article-title":"Revisional surgery or pharmacotherapy for insufficient weight loss and weight regain after primary bariatric procedure: a descriptive study","volume":"32","author":"Dharmaratnam","year":"2022","journal-title":"Obes Surg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-022-01403-9","article-title":"Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery","volume":"27","author":"Muratori","year":"2022","journal-title":"Eat Weight Disord"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-021-05884-y","article-title":"Effectiveness and safety of liraglutide in managing inadequate weight loss and weight regain after primary and revisional bariatric surgery: anthropometric and cardiometabolic outcomes","volume":"32","author":"Elhag","year":"2022","journal-title":"Obes Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e12323","DOI":"10.1111\/cob.12323","article-title":"Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post-bariatric surgery","volume":"9","author":"Wharton","year":"2019","journal-title":"Clin Obes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1089\/bari.2018.0037","article-title":"Weight loss medications in older adults after bariatric surgery for weight regain or inadequate weight loss: a multicenter study","volume":"13","author":"Stanford","year":"2018","journal-title":"Bariatr Surg Pract Patient Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/children5090116","article-title":"Weight loss medications in young adults after bariatric surgery for weight regain or inadequate weight loss: a multicenter study","volume":"5","author":"Toth","year":"2018","journal-title":"Children (Basel)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-018-3393-7","article-title":"Efficacy of high-dose liraglutide as an adjunct for weight loss in patients with prior bariatric surgery","volume":"28","author":"Rye","year":"2018","journal-title":"Obes Surg"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2017.10.002","article-title":"Efficacy of adjuvant weight loss medication after bariatric surgery","volume":"14","author":"Nor Hanipah","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2016.02.013","article-title":"Effectiveness and tolerability of liraglutide in patients with type 2 diabetes mellitus and obesity after bariatric surgery","volume":"12","author":"Gorgojo-Mart\u00ednez","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1111\/cob.70001","article-title":"Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for weight recidivism after sleeve gastrectomy","volume":"15","author":"Bahdi","year":"2025","journal-title":"Clin Obes"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-025-07671-5","article-title":"A randomized, double-blind, two-way cross-over study to evaluate the efficacy of liraglutide treatment in patients undergoing transoral outlet reduction endoscopy for weight regain post Roux-en-Y gastric bypass","volume":"35","author":"Lahooti","year":"2025","journal-title":"Obes Surg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2024.08.037","article-title":"A randomized, double-blind, placebo-controlled trial of weight loss using liraglutide 3.0 mg for weight recurrence after Roux-en-Y gastric bypass","volume":"21","author":"Lofton","year":"2025","journal-title":"Surg Obes Relat Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000990","article-title":"Boosting weight loss after conversional Roux-en-Y gastric bypass with liraglutide and placebo use: a double-blind randomized controlled trial","volume":"110","author":"Hany","year":"2024","journal-title":"Int J Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2023.2930","article-title":"Safety and efficacy of liraglutide, 3.0 mg, once daily vs placebo in patients with poor weight loss following metabolic surgery: the BARI-OPTIMISE randomized clinical trial","volume":"158","author":"Mok","year":"2023","journal-title":"JAMA Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30157-3","article-title":"Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Miras","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11695-021-05426-6","article-title":"Reversal of long-term weight regain after Roux-en-Y gastric bypass using liraglutide or surgical revision: a prospective study","volume":"31","author":"Horber","year":"2021","journal-title":"Obes Surg"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-024-07225-1","article-title":"Impact of probiotics on gastrointestinal function and metabolic status after Roux-en-Y gastric bypass: a double-blind randomized trial","volume":"34","author":"Melali","year":"2024","journal-title":"Obes Surg"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/nu16132055","article-title":"Preoperative multistrain probiotic supplementation does not affect body weight changes or cardiometabolic risk factors in bariatrics: randomized double-blind placebo-controlled clinical trial","volume":"16","author":"Potrykus","year":"2024","journal-title":"Nutrients"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-021-05222-2","article-title":"Effects of Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 supplementation on nutritional and metabolic parameters in the early postoperative period after Roux-en-Y gastric bypass: a randomized, double-blind, placebo-controlled trial","volume":"31","author":"Ramos","year":"2021","journal-title":"Obes Surg"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-020-04894-6","article-title":"The metabolic effects of pre-probiotic supplementation after Roux-en-Y gastric bypass (RYGB) surgery: a prospective, randomized controlled study","volume":"31","author":"Calikoglu","year":"2021","journal-title":"Obes Surg"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-018-3280-2","article-title":"Probiotic supplementation in morbid obese patients undergoing one anastomosis gastric bypass\u2013mini gastric bypass (OAGB-MGB) surgery: a randomized, double-blind, placebo-controlled, clinical trial","volume":"28","author":"Karbaschian","year":"2018","journal-title":"Obes Surg"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2017.210","article-title":"Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial","volume":"42","author":"Sherf-Dagan","year":"2018","journal-title":"Int J Obes (Lond)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5542626","article-title":"Probiotics can further reduce waist circumference in adults with morbid obesity after bariatric surgery: a systematic review and meta-analysis of randomized controlled trials","volume":"2021","author":"Zhang","year":"2021","journal-title":"Evid Based Complement Altern Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-024-07599-2","article-title":"Use of probiotics and synbiotics in the treatment of small intestinal bacterial overgrowth (SIBO) and other gastrointestinal symptoms after metabolic bariatric surgery: a systematic review and meta-analysis","volume":"35","author":"Wagner","year":"2025","journal-title":"Obes Surg"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2022.01.120","article-title":"Probiotics for gallstone prevention in patients with bariatric surgery: a prospective randomized trial","volume":"45","author":"Han","year":"2022","journal-title":"Asian J Surg"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-023-06893-9","article-title":"Role of ursodeoxycholic acid in the prevention of gallstones formation in bariatric patients: a systematic review and meta-analysis of randomised trials","volume":"33","author":"Sharma","year":"2023","journal-title":"Obes Surg"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab883","article-title":"Prebiotic to improve calcium absorption in postmenopausal women after gastric bypass: a randomized controlled trial","volume":"107","author":"Wu","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-023-01375-5","article-title":"Effects of probiotics in patients with morbid obesity undergoing bariatric surgery: a systematic review and meta-analysis","volume":"47","author":"Wang","year":"2023","journal-title":"Int J Obes (Lond)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-025-01763-x","article-title":"Impact of bariatric\u00a0surgery on gut microbiota in obese patients: A systematic review","volume":"44","author":"Mohammadzadeh","year":"2025","journal-title":"Indian J Gastroenterol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/nu17081303","article-title":"Effects of GLP-1 analogues and agonists on the gut microbiota: A systematic review","volume":"17","author":"Gofron","year":"2025","journal-title":"Nutrients"},{"key":"B51","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12916-025-04200-0","article-title":"Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications","volume":"23","author":"Wu","year":"2025","journal-title":"BMC Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1680182\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:33:46Z","timestamp":1770183226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1680182\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":51,"alternative-id":["10.3389\/fendo.2026.1680182"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1680182","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"article-number":"1680182"}}